These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate. Dominguez-Mozo MI; Casanova I; De Torres L; Aladro-Benito Y; Perez-Perez S; Garcia-Martínez A; Gomez P; Abellan S; De Antonio E; Lopez-De-Silanes C; Alvarez-Lafuente R Front Immunol; 2022; 13():904683. PubMed ID: 35774792 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma. Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608 [TBL] [Abstract][Full Text] [Related]
48. Gene Regulatory Networks in Peripheral Mononuclear Cells Reveals Critical Regulatory Modules and Regulators of Multiple Sclerosis. Gnanakkumaar P; Murugesan R; Ahmed SSSJ Sci Rep; 2019 Sep; 9(1):12732. PubMed ID: 31484947 [TBL] [Abstract][Full Text] [Related]
49. MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators. Perdaens O; van Pesch V J Neuroimmunol; 2024 Jan; 386():578196. PubMed ID: 38101084 [TBL] [Abstract][Full Text] [Related]
50. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome. Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495 [TBL] [Abstract][Full Text] [Related]
51. MiR-126: a novel route for natalizumab action? Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267 [TBL] [Abstract][Full Text] [Related]
52. Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs. Yu J; Yu C; Feng B; Zhan X; Luo N; Yu X; Zhou Q BMC Nephrol; 2019 Aug; 20(1):336. PubMed ID: 31455266 [TBL] [Abstract][Full Text] [Related]
53. Down-regulation of miR-378a-3p induces decidual cell apoptosis: a possible mechanism for early pregnancy loss. Hong L; Yu T; Xu H; Hou N; Cheng Q; Lai L; Wang Q; Sheng J; Huang H Hum Reprod; 2018 Jan; 33(1):11-22. PubMed ID: 29165645 [TBL] [Abstract][Full Text] [Related]
54. Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature. Sheng WH; Sheng KT; Zhao YX; Li H; Zhou JL; Yao HY; Li XH Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3635-42. PubMed ID: 26502853 [TBL] [Abstract][Full Text] [Related]
55. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation. Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738 [TBL] [Abstract][Full Text] [Related]
56. Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains. Tripathi A; Volsko C; Datta U; Regev K; Dutta R Ann Clin Transl Neurol; 2019 May; 6(5):854-862. PubMed ID: 31139683 [TBL] [Abstract][Full Text] [Related]